about
sameAs
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart LesionsImpact of Contact Force Technology on Atrial Fibrillation Ablation: A Meta-AnalysisCatheter Ablation for Long-Standing Persistent Atrial FibrillationFeasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.Photoacoustic Characterization of Radiofrequency Ablation LesionsIn vitro photoacoustic visualization of myocardial ablation lesions.Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: role of cardiac electroanatomical mapping and biopsy.Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.Phrenic nerve injury after catheter ablation: should we worry about this complication?Left Atrial Appendage Morphology and Physiology: "The Missing Piece in the Puzzle".Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies.Locating the right phrenic nerve by imaging the right pericardiophrenic artery with computerized tomographic angiography: implications for balloon-based procedures.Radiofrequency ablation of drug refractory ventricular tachycardia related to cocaine use: a feasibility, safety, and efficacy studyHospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study.Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation.Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience.Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis.Exchanging Catheters Over a Single Transseptal Sheath During Left Atrial Ablation is Associated with a Higher Risk for Silent Cerebral Events.Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review.Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortiumLeft atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: A meta-analysis.Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.Outcomes in Women Undergoing Electrophysiological Procedures.Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trialOmega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation.Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia.Management of refractory atrial fibrillation post surgical ablation.Rational patient selection for catheter ablation of atrial fibrillation.Usefulness of statins in preventing atrial fibrillation in patients with permanent pacemaker: a systematic review.Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.Endocardial and epicardial mapping and catheter ablation of post myocardial infarction ventricular tachycardia: A substrate modification approach.Outcome of invasive electrophysiological procedures and gender: are males and females the same?Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators.Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.The pharmaceutical pipeline for atrial fibrillation.Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.Examining the safety of amiodarone.Quality of life and patient-centered outcomes following atrial fibrillation ablation: short- and long-term perspectives to improving care.Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mechanical prosthetic valve.
P50
Q26764853-B94F1D38-FEC7-48F4-AFA1-436ADB71B646Q26782647-0491E25B-B6C4-4E36-8531-E5970A476AD5Q26797441-75695525-EC5D-4517-AA70-0805A2D17E52Q30316734-FCAE8944-1B0A-4A8E-A226-5FA97EB22BCEQ30403294-1962FF47-26A7-4138-8496-33E64EFD5B58Q30421753-FE44A82E-019F-42B7-AFD4-2B69328DE2A8Q33160277-3EF9F1EB-BE4E-4F5E-A089-044F1275442FQ33161166-7D4C3369-3D11-49A9-8722-46940F2FA9DEQ33247971-6DFC603A-2D15-4566-8C54-EBDEF7D4CD4BQ33360982-579A38AF-C9F5-46BE-9FA7-29860A1D6B25Q33393194-7D3EA7E2-55A3-4FD9-B201-267439E02B15Q33546944-607DAEF6-6E6E-474A-B7D3-DCBCEAAD5A94Q34617342-8CE1EE2D-7FD5-4CD0-94D0-254232FCCF6CQ34794812-66B676D5-C3AE-4F36-9C60-3645E26C52D8Q35057284-5EEFBE81-0D75-4223-B200-FC8A58360FB0Q35086260-87B9A498-03AF-4030-9D18-C4A13D95DD00Q35194919-DA7A6FE1-87EF-43FD-A995-C3727247110CQ35435548-647019E3-7B4E-4DAC-97F7-973A86DF11C7Q35537445-D86B09DC-1C55-4FEB-9029-DEA01926B287Q35915270-ED2E17C6-9724-450B-AD0F-C0547D4B5626Q35970828-18C16C4A-4837-4AD1-A0C1-90B3A89DD358Q35995550-1095BA19-973A-4C45-BCB5-087E76A30FD7Q36458924-7AEBBCA9-300E-495F-AFF5-BD380F348309Q37313974-9FD743EA-5C1F-4F7E-9565-1ACCFA3089C8Q37353363-8B354C3D-8C02-4219-8498-3EB80B6594C6Q37398096-6D17046A-C851-42B7-91B4-C6C5972843EBQ37468140-E3B20618-E4AF-4037-8C28-E5AF219F0428Q37523151-089D484E-C00C-4F70-A045-0C98FDFE3B62Q37587470-33F29540-1F7B-42AB-9885-3214CCE98A9AQ37699966-A00DB7B9-37BE-4819-9C10-982D38EA1FAEQ37728147-31088AE2-07DE-4FD1-B012-4B497E3F18CCQ37732014-76C8150E-53E9-4DC0-B114-4DEDD3141FABQ37801438-DEF08E19-1BE0-4FD9-8137-2A01FB3B44BFQ37805931-4FDD1118-2B98-4DCB-9F9B-F4013027D054Q37806303-A74D5733-3B68-48BE-9EB6-2041BF28CDF1Q37821928-25380F04-F044-44F9-AE9E-64EF262DDFB3Q37970932-206361FF-A522-473A-9F51-965703638ED8Q37983124-FCC356AA-F7FB-4380-AFC5-E46AAAE730A3Q38036333-8E7DC5E2-7A8E-44DF-996F-311D47C9EA02Q38045927-ED4C3F8A-A4FF-45F7-B43B-B820BD868CAC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luigi Di Biase
@ast
Luigi Di Biase
@en
Luigi Di Biase
@es
Luigi Di Biase
@nl
Luigi Di Biase
@sl
type
label
Luigi Di Biase
@ast
Luigi Di Biase
@en
Luigi Di Biase
@es
Luigi Di Biase
@nl
Luigi Di Biase
@sl
prefLabel
Luigi Di Biase
@ast
Luigi Di Biase
@en
Luigi Di Biase
@es
Luigi Di Biase
@nl
Luigi Di Biase
@sl
P106
P21
P31
P496
0000-0001-6508-4047